Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Alkhouri

Showing results (131-140 of 306) with videos related to

Pageof 31
Sort By:
Hepatology (Baltimore, Md.)|March 19, 2016
The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemicRachel Abou Mrad, Nawal Merjaneh, Ghassan Mubarak, et al.
Lancet (London, England)|August 23, 2025
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRohit Loomba, Erin Morgan, Keyvan Yousefi, et al.
Gut|December 15, 2022
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver diseaseTracey G Simon, Bjorn Roelstraete, Naim Alkhouri, et al.
Hepatology (Baltimore, Md.)|October 5, 2011
Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitisNaim Alkhouri, Gaurav Kistangari, Carla Campbell, et al.
World Journal of Gastroenterology|December 6, 2008
Johanson-Blizzard syndrome with mild phenotypic features confirmed by UBR1 gene testingNaim Alkhouri, Barbara Kaplan, Marsha Kay, et al.
The American Journal of Gastroenterology|June 12, 2013
Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in childrenAriel E Feldstein, Naim Alkhouri, Rita De Vito, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2023
The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosisMarcelo Kugelmas, Mazen Noureddin, Nadege Gunn, et al.
The Journal of Surgical Research|October 19, 2013
Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinomaSamiksha Bansal, Michael Berk, Naim Alkhouri, et al.
International Journal of Hepatology|February 13, 2020
Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 StudiesFred Poordad, Norah A Terrault, Naim Alkhouri, et al.
Digestive Diseases and Sciences|January 26, 2020
Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver DiseaseAmandeep Singh, Hina Amin, Rajat Garg, et al.
Pageof 31

Showing results (131-140 of 306) with videos related to

Sort By:
Pageof 31
Hepatology (Baltimore, Md.)|March 19, 2016
The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemicRachel Abou Mrad, Nawal Merjaneh, Ghassan Mubarak, et al.
Lancet (London, England)|August 23, 2025
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trialRohit Loomba, Erin Morgan, Keyvan Yousefi, et al.
Gut|December 15, 2022
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver diseaseTracey G Simon, Bjorn Roelstraete, Naim Alkhouri, et al.
Hepatology (Baltimore, Md.)|October 5, 2011
Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitisNaim Alkhouri, Gaurav Kistangari, Carla Campbell, et al.
World Journal of Gastroenterology|December 6, 2008
Johanson-Blizzard syndrome with mild phenotypic features confirmed by UBR1 gene testingNaim Alkhouri, Barbara Kaplan, Marsha Kay, et al.
The American Journal of Gastroenterology|June 12, 2013
Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in childrenAriel E Feldstein, Naim Alkhouri, Rita De Vito, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 3, 2023
The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosisMarcelo Kugelmas, Mazen Noureddin, Nadege Gunn, et al.
The Journal of Surgical Research|October 19, 2013
Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinomaSamiksha Bansal, Michael Berk, Naim Alkhouri, et al.
International Journal of Hepatology|February 13, 2020
Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 StudiesFred Poordad, Norah A Terrault, Naim Alkhouri, et al.
Digestive Diseases and Sciences|January 26, 2020
Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver DiseaseAmandeep Singh, Hina Amin, Rajat Garg, et al.
Pageof 31